Monthly Archives: November 2011

October 5 2011 Progression of Lung Fibrosis Blocked in Mouse Model

Study points to a phosphorylation pathway that may contribute to the development of lung injury and fibrosis   A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , , | Leave a comment

September 26 2011 New Data Demonstrate Longer-Term Safety Profile of Esbriet (Pirfenidone)

Announcement follows Esbriet (pirfenidone) availability to IPF patients in Germany AMSTERDAM, Sept. 26, 2011 /PRNewswire/ — InterMune, Inc. (NASDAQ:  ITMN) today reported that new data(1) was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , , , , , | Leave a comment

September 24 2011 Cancer Drug Equally Effective In Treating Scleroderma, Pulmonary Fibrosis

A drug that is used to treat cancer may be equally effective in treating diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma. The drug, with the generic name bortezomib, stopped the production … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , , | Leave a comment

September 21 2011 China SFDA approves F647/ Pirfenidone for the treatment of Idiopathic Pulmonary Fibrosis

TOKYO, September 22, 2011 Read the entire article at: http://www.gnipharma.com/english/news/download/TSE20110922.pdf or go to www.ipftoday.com for more news.

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , , | Leave a comment

September 21 2011 Drug Shows Promise Against Deadly Lung Disease

By Amanda Gardner HealthDay Reporter WEDNESDAY, Sept. 21 (HealthDay News) — An experimental drug may offer a thin ray of hope to people suffering from the rapidly fatal lung disease known as idiopathic pulmonary fibrosis. The compound, currently known only … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , , | Leave a comment

September 20 2011 Estrogen treatment may help reverse severe pulmonary hypertension

Estrogen treatment may help reverse severe pulmonary hypertension Date: 09/15/2011 Contact: Rachel Champeau UCLA researchers have found that the hormone estrogen may help reverse advanced pulmonary hypertension, a rare and serious condition that affects 2 million to 3 million individuals … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , | Leave a comment

September 19 2011 Biotechnology Firm ImmuneWorks Supports Pulmonary Fibrosis Week by Increasing National Recruitment Efforts to Enroll Idiopathic Pulmonary Fibrosis (IPF) Patients in Clinical Trial

INDIANAPOLIS, IN, Sep 19, 2011 (MARKETWIRE via COMTEX) — Biotechnology firm, ImmuneWorks, is ramping up efforts to support National Pulmonary Fibrosis (PF) Awareness Week (September 18-24). IPF is one of the most fatal, yet publicly unrecognized, diseases claiming more and … Continue reading

Posted in IPF, Medical, Pulmonary Fibrosis | Tagged , , | Leave a comment